HRP20200941T1 - FARMACEUTSKI PRIPRAVAK KOJI SADRŽI REKOMBINANTNI hCG - Google Patents

FARMACEUTSKI PRIPRAVAK KOJI SADRŽI REKOMBINANTNI hCG Download PDF

Info

Publication number
HRP20200941T1
HRP20200941T1 HRP20200941TT HRP20200941T HRP20200941T1 HR P20200941 T1 HRP20200941 T1 HR P20200941T1 HR P20200941T T HRP20200941T T HR P20200941TT HR P20200941 T HRP20200941 T HR P20200941T HR P20200941 T1 HRP20200941 T1 HR P20200941T1
Authority
HR
Croatia
Prior art keywords
pharmaceutical preparation
recombinant hcg
per
cell line
rhcg
Prior art date
Application number
HRP20200941TT
Other languages
English (en)
Croatian (hr)
Inventor
Ian Cottingham
Daniel Plaksin
Richard Boyd White
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of HRP20200941T1 publication Critical patent/HRP20200941T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HRP20200941TT 2009-10-05 2010-10-04 FARMACEUTSKI PRIPRAVAK KOJI SADRŽI REKOMBINANTNI hCG HRP20200941T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09252360 2009-10-05
EP10763000.6A EP2486051B1 (en) 2009-10-05 2010-10-04 Pharmaceutical preparation comprising recombinant hcg
PCT/GB2010/001854 WO2011042688A1 (en) 2009-10-05 2010-10-04 Pharmaceutical preparation comprising recombinant hcg

Publications (1)

Publication Number Publication Date
HRP20200941T1 true HRP20200941T1 (hr) 2020-09-18

Family

ID=41471027

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200941TT HRP20200941T1 (hr) 2009-10-05 2010-10-04 FARMACEUTSKI PRIPRAVAK KOJI SADRŽI REKOMBINANTNI hCG

Country Status (25)

Country Link
US (5) US8975226B2 (enExample)
EP (2) EP2486051B1 (enExample)
JP (6) JP6176924B2 (enExample)
KR (7) KR20230012104A (enExample)
CN (1) CN107050434B (enExample)
AR (2) AR079876A1 (enExample)
AU (1) AU2010304922B2 (enExample)
BR (1) BR112012007990A2 (enExample)
CA (1) CA2776790A1 (enExample)
DK (1) DK2486051T3 (enExample)
ES (2) ES3036152T3 (enExample)
HR (1) HRP20200941T1 (enExample)
HU (1) HUE050793T2 (enExample)
IL (3) IL218548A (enExample)
IN (1) IN2012DN02073A (enExample)
JO (1) JOP20200039A1 (enExample)
LT (1) LT2486051T (enExample)
MX (1) MX2012003951A (enExample)
PL (1) PL2486051T3 (enExample)
PT (1) PT2486051T (enExample)
RS (1) RS60413B1 (enExample)
RU (2) RU2588650C2 (enExample)
SI (1) SI2486051T1 (enExample)
TW (2) TWI604850B (enExample)
WO (1) WO2011042688A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2691119B1 (en) 2011-03-31 2018-08-01 Ferring B.V. Pharmaceutical preparation
EP2717904A1 (en) * 2011-06-06 2014-04-16 Ferring BV Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
WO2013093760A2 (en) * 2011-12-19 2013-06-27 Grifols, S.A. Compositions, methods, and kits for preparing sialylated recombinant proteins
ES2738593T3 (es) 2012-12-10 2020-01-23 Seikagaku Kogyo Co Ltd Factor C recombinante novedoso y método para producir el mismo, y método para medir endotoxina
EP3237608B1 (en) * 2014-12-22 2019-10-09 F. Hoffmann-La Roche AG Cmp-dependent sialidase activity
EP3286209B1 (en) * 2015-04-24 2020-11-25 Ferring BV Method of production of gonadotrophin
WO2016207353A1 (en) 2015-06-26 2016-12-29 Ferring B.V. Methods of purification and/or viral inactivation
LT3787667T (lt) * 2018-04-30 2025-05-12 Ferring B.V. Kompozicija, skirta kontroliuojamam kiaušidžių stimuliavimui
PH12022552029A1 (en) * 2020-02-05 2023-11-20 Novartis Ag Cho cell expressing il-15 heterodimers
CN116199742B (zh) * 2022-07-06 2025-01-24 华兰基因工程有限公司 一种重组人绒毛膜促性腺激素Fc融合蛋白制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840896A (en) * 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
DK49987A (da) 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
IT1206302B (it) 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
EP0814841B1 (en) * 1995-03-21 2001-12-05 Applied Research Systems ARS Holding N.V. Hcg liquid formulations
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
US8530190B1 (en) 1997-06-25 2013-09-10 Merck Serono Sa Disulfide crosslinked glycoprotein hormone analogs, and their preparation and use
US6500627B1 (en) 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
US7304031B2 (en) * 2001-10-29 2007-12-04 Crucell Holland B.V. Methods and means for producing proteins with predetermined post-translational modifications
AR023869A1 (es) * 1999-05-07 2002-09-04 Serono Lab Gonadotropinas
MXPA02007871A (es) * 2000-02-22 2003-02-10 Applied Research Systems Proceso para la purificacion de gonadotropina corionica humana (hcg) y gonadotropina corionica humana recombinante purificada mediante este proceso.
AR036592A1 (es) 2001-09-12 2004-09-22 Applied Research Systems Uso de gch en la hiperestimulacion ovarica controlada
WO2004099231A2 (en) * 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
PL369606A1 (en) * 2001-10-22 2005-05-02 Applied Research Systems Ars Holding N.V. Gonadotrophins for folliculogenesis
AU2002224199A1 (en) * 2001-10-29 2003-06-23 Crucell Holland B.V. Methods and means for producing proteins with predetermined post-translational modifications
CN1374525A (zh) * 2001-12-31 2002-10-16 陕西超英生物医学研究开发有限公司 一种抗体芯片、其制备技术及其检测方法
EA200501548A1 (ru) * 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
JP4518464B2 (ja) 2003-06-30 2010-08-04 ミヨシ油脂株式会社 紙類処理剤及び紙類
US8017388B2 (en) * 2003-08-18 2011-09-13 Glycotope Gmbh Tumour cell lines and uses thereof
EP1711834B1 (en) * 2004-02-04 2010-08-04 Centre National De La Recherche Scientifique Process for screening glycoform-specific antibodies
CN1926242B (zh) * 2004-02-13 2013-01-16 格莱克托普有限公司 高活性糖蛋白加工条件及其有效生产方法
CN101137396A (zh) * 2005-03-11 2008-03-05 弗雷泽纽斯卡比德国有限公司 由无活性初始材料制备生物活性糖蛋白
DE112006002122B4 (de) * 2005-08-15 2016-09-22 Continental Automotive Systems, Inc. ( n. d. Ges. d. Staates Delaware ) Dieselabgas-Kohlenwasserstoff-Dosierventil für Fahrzeuge
RU2309411C2 (ru) * 2005-11-24 2007-10-27 Ростовский НИИ акушерства и педиатрии МЗ РФ Способ отбора пациенток с синдромом "пустых" фолликулов для проведения программы эко и пэ донорскими ооцитами
KR100809945B1 (ko) * 2006-02-01 2008-03-05 대한민국 인체장내정상세균총 특이반응 ｄｎａ칩 및 이를 이용한인체장내정상세균총의 변화에 의한 인체 위해성의 평가방법
CN101516388B (zh) * 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
JP2010505874A (ja) * 2006-10-03 2010-02-25 ノヴォ ノルディスク アー／エス ポリペプチドコンジュゲートの精製方法
TWI488640B (zh) * 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2691119B1 (en) * 2011-03-31 2018-08-01 Ferring B.V. Pharmaceutical preparation
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
US10526390B2 (en) 2020-01-07
RS60413B1 (sr) 2020-07-31
RU2016118236A3 (enExample) 2019-09-18
JP7196244B2 (ja) 2022-12-26
CA2776790A1 (en) 2011-04-14
EP3611185B1 (en) 2025-04-30
PT2486051T (pt) 2020-06-17
KR20190067256A (ko) 2019-06-14
JP2023075144A (ja) 2023-05-30
BR112012007990A2 (pt) 2017-07-25
PL2486051T3 (pl) 2020-09-07
JP7292153B2 (ja) 2023-06-16
JP2020000246A (ja) 2020-01-09
KR20170133531A (ko) 2017-12-05
AU2010304922B2 (en) 2014-11-06
CN107050434B (zh) 2021-07-27
KR101987982B1 (ko) 2019-06-11
RU2588650C2 (ru) 2016-07-10
DK2486051T3 (da) 2020-06-22
KR101804479B1 (ko) 2017-12-05
IL267556A (en) 2019-08-29
JP2016074680A (ja) 2016-05-12
JP2013506708A (ja) 2013-02-28
US8975226B2 (en) 2015-03-10
US20200247863A1 (en) 2020-08-06
KR20210014767A (ko) 2021-02-09
ES2798258T3 (es) 2020-12-10
KR102213154B1 (ko) 2021-02-05
HUE050793T2 (hu) 2021-01-28
IL218548A0 (en) 2012-05-31
KR20120094909A (ko) 2012-08-27
TWI604850B (zh) 2017-11-11
US11292824B2 (en) 2022-04-05
EP2486051A1 (en) 2012-08-15
US9676835B2 (en) 2017-06-13
IN2012DN02073A (enExample) 2015-08-21
JP6580104B2 (ja) 2019-09-25
JOP20200039A1 (ar) 2022-10-30
US12234272B2 (en) 2025-02-25
US20180030107A1 (en) 2018-02-01
KR20210141771A (ko) 2021-11-23
TW201632198A (zh) 2016-09-16
AR079876A1 (es) 2012-02-29
IL250733A0 (en) 2017-04-30
KR102489143B1 (ko) 2023-01-13
CN102549011A (zh) 2012-07-04
JP6310440B2 (ja) 2018-04-11
KR20230012104A (ko) 2023-01-25
IL250733B (en) 2019-07-31
US20140249082A1 (en) 2014-09-04
JP2021176867A (ja) 2021-11-11
AR125991A2 (es) 2023-08-30
JP2018076296A (ja) 2018-05-17
TW201113030A (en) 2011-04-16
ES3036152T3 (en) 2025-09-15
MX2012003951A (es) 2012-05-29
JP6176924B2 (ja) 2017-08-09
SI2486051T1 (sl) 2020-08-31
TWI532495B (zh) 2016-05-11
LT2486051T (lt) 2020-07-10
EP3611185A1 (en) 2020-02-19
RU2012112907A (ru) 2013-11-10
CN107050434A (zh) 2017-08-18
WO2011042688A1 (en) 2011-04-14
IL218548A (en) 2017-03-30
EP2486051B1 (en) 2020-03-25
US20220340634A1 (en) 2022-10-27
AU2010304922A1 (en) 2012-03-29
KR20190028823A (ko) 2019-03-19
RU2724528C2 (ru) 2020-06-23
RU2016118236A (ru) 2018-10-29
US20130023476A1 (en) 2013-01-24

Similar Documents

Publication Publication Date Title
HRP20200941T1 (hr) FARMACEUTSKI PRIPRAVAK KOJI SADRŽI REKOMBINANTNI hCG
AR077942A1 (es) Variantes de glucoamilasa
HRP20241187T1 (hr) Rekombinantni fsh koji uključuje alfa 2,3- i alfa 2,6-sijalilaciju
MY161268A (en) PEPTIDE OR PEPTIDE COMPLEX BINDING TO α2 INTEGRIN AND METHODS AND USES INVOLVING THE SAME
IL216861A (en) Nucleic Acids Encoded by Activin Binding Polypeptides, gdf8 or gdf11
WO2012103496A3 (en) Expression of soluble viral fusion glycoproteins in mammalian cells
BRPI1008971A2 (pt) métodos para preparar uma proteína biológica condicionalmente ativa, e um modificador de resposta biológica condicionalmente ativo, proteína biológica condicionalmente ativa, e, composição farmacêutica
EP4276180A3 (en) Clostridium histolyticum enzyme
AR077757A1 (es) Composiciones de proteinas de fusion del virus sincicial respiratorio (rsv) y metodos para su preparacion
MX2012013375A (es) Peptido c pegilado.
CL2013000052A1 (es) Proceso para la produccion de lignina precipitada a partir de licor negro; lignina precipitada; solucion que comprende a dicha lignina precipitada; y uso de dicha lignina precipitada.
WO2013093760A3 (en) Compositions, methods, and kits for preparing sialylated recombinant proteins
HUE042945T2 (hu) Kvetiapin zsírsav-konjugátumai, eljárás ugyanannak elkészítésére és felhasználására
ECSP12011787A (es) Polipéptidos para unión al "receptor para productos finales de glicosilación avanzada" así como composiciones y métodos que implican a los mismos
AR083114A1 (es) Produccion de anticuerpos de fucosa baja en celulas de rata h4-ii-e
BR112015013933A2 (pt) fermentação sequencial de hidrolisato e sólidos de uma hidrólise de ácido diluído de biomassa para produzir produtos de fermentação
IL212580A0 (en) Cells modified to express lipid - linked oligosaccharide flippase activity, methods of producing the same and uses thereof
IN2012DN03209A (enExample)
WO2012126123A8 (en) Method of recovering plant-derived proteins
SMT201300059B (it) Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione
AP2637A (en) Method for preparing main hydrolysate by hydrolizing plant cellulose materials with concentrated sulfuric acid
TR201901259T4 (tr) Karaciğere özgü tanı için hidrofobik modifiye peptidler.
MX346787B (es) Sulfato de controitina similar al de tiburon y proceso para la preparacion del mismo.
BRPI0812612A2 (pt) processo de adaptação de cepa, células de fibroblasto de pinto primárias, processo de preparação de vacina contra a raiva, vacina contra a raiva, composição farmacêutica, método de vacina e uso da vacina
WO2014006452A3 (en) Rapid alkalinization factor peptides for delivery of nucleic acid molecules into cells